528 related articles for article (PubMed ID: 19383871)
1. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
2. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
3. Alteration of bone cell function by RANKL and OPG in different in vitro models.
Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
[TBL] [Abstract][Full Text] [Related]
4. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
5. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
6. FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts.
Lammi J; Aarnisalo P
Mol Cell Endocrinol; 2008 Nov; 295(1-2):87-93. PubMed ID: 18809462
[TBL] [Abstract][Full Text] [Related]
7. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells.
Li CF; Hughes-Fulford M
J Bone Miner Res; 2006 Jun; 21(6):946-55. PubMed ID: 16753025
[TBL] [Abstract][Full Text] [Related]
9. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.
Cornish J; Callon KE; Bava U; Watson M; Xu X; Lin JM; Chan VA; Grey AB; Naot D; Buchanan CM; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E117-22. PubMed ID: 16912056
[TBL] [Abstract][Full Text] [Related]
10. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
Fakhry A; Ratisoontorn C; Vedhachalam C; Salhab I; Koyama E; Leboy P; Pacifici M; Kirschner RE; Nah HD
Bone; 2005 Feb; 36(2):254-66. PubMed ID: 15780951
[TBL] [Abstract][Full Text] [Related]
11. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
Yoshida T; Flegler A; Kozlov A; Stern PH
J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
[TBL] [Abstract][Full Text] [Related]
12. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
[TBL] [Abstract][Full Text] [Related]
13. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
Coetzee M; Haag M; Kruger MC
J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade.
Chen JR; Shankar K; Nagarajan S; Badger TM; Ronis MJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):50-9. PubMed ID: 17916759
[TBL] [Abstract][Full Text] [Related]
15. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
16. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.
Chen JR; Haley RL; Hidestrand M; Shankar K; Liu X; Lumpkin CK; Simpson PM; Badger TM; Ronis MJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1182-90. PubMed ID: 16971503
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels.
Kondo T; Kitazawa R; Yamaguchi A; Kitazawa S
J Cell Biochem; 2008 Jan; 103(1):335-45. PubMed ID: 17516544
[TBL] [Abstract][Full Text] [Related]
18. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells.
Kajiya H; Ito M; Ohshima H; Kenmotsu S; Ries WL; Benjamin IJ; Reddy SV
J Cell Biochem; 2006 Apr; 97(6):1362-9. PubMed ID: 16365894
[TBL] [Abstract][Full Text] [Related]
19. Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio.
Rucci N; Rufo A; Alamanou M; Teti A
J Cell Biochem; 2007 Feb; 100(2):464-73. PubMed ID: 16927271
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
